期刊文献+

连续性血液净化在治疗重症脓毒血症中的应用 被引量:33

The Effect of Continuous Blood Purification in Treatment of Patients with Severe Sepsis Patients
下载PDF
导出
摘要 目的:探讨连续性血液净化(CBP)治疗重症脓毒血症患者的疗效。方法:对30例重症脓毒血症患者,在CBP治疗前、治疗期间及治疗结束后分别监测患者血流动力学参数、呼吸机参数及急性生理和慢性健康状况评分(APACHEⅡ),测定动脉血气、肾功能、电解质,记录多巴胺用量及呼吸机参数。结果:所有治疗均进行顺利,经过CBP治疗,患者血流动力学较治疗前改善;氧合指数(PaO2/FiO2)、动脉氧分压(PaO2)均升高、吸入氧浓度(FiO2)下调,与治疗前比较差异有统计学意义(P<0.05);平均动脉压(MBP)升高,多巴胺的需要量明显减少(P<0.05);APACHEⅡ评分、肌酐、尿素氮、血钾水平较治疗前明显降低(P<0.05)。结论:CBP能改善重症脓毒血症患者的血流动力学状况及肺氧合功能,维持内环境稳定,是一种可行、有益的辅助治疗重症脓毒血症的方法。 Objective :To discuss the effect of continuous blood purification ( CBP ) in treatment of patients with severe sepsis patients.Methods: 30 patients with severe sepsis patients, in the CBP before treatment, during treatment and after treatment respectively monitor the hemodynamics of patients with ventilator parameters, and acute physiology and chronic health evaluation ( APACHE Ⅱ ), arterial blood gas measurements, renal function, electrolyte, recording of dopamine content and ventilator parameters.Results:All treatments were performed smoothly, after CBP treatment than before treatment, patients with hemodynamic improvement ; oxygenation index (PaO2/FiO2 ), arterial partial pressure of oxygen (PaO2)were increased, inspired oxygen concentration ( FiO2 ) down, and before treatment has significant difference (P〈0.05) ; mean arterial pressure ( MBP elevated dopamine ), the need quantity decreased obviously (P〈0.05) ; APACHE II score, creatinine, blood urea nitrogen, serum potassium levels significantly decreased compared with those before treatment ( P〈0.05 ).Conclusion:CBP can improve in patients with severe sepsis hemodynamics and oxygenation function, to maintain a stable environment within, is a practical, useful adjunctive therapy in severe sepsis method.
出处 《中国医学创新》 CAS 2012年第14期16-17,共2页 Medical Innovation of China
基金 广东省东莞市医疗卫生类科研项目(项目编号:200910515000100)
关键词 重症脓毒血症 连续性血液净化 血流动力学 CSevere sepsis Continuous blood purification Hemodynamies
  • 相关文献

参考文献6

  • 1Riedemann N C,Reward P A.Novel strategies for the treatment of sepsis[J].NatMed,2003,9(5):517-524.
  • 2Bernard G R,Vincent J L,Laterre P F,et al.Efficacy and safety of recombinant human activated p rotein C for severe sep sis[J].N Engl J M ed,2001,344 (10):6992-6999.
  • 3Annane D,Aegerter P,Guincestre M C,et al.Current ep idemi2 ology of septic shock:the CUB2Rea Network[J].Am J Respir Crit CareMed,2003,168 (2):16521-16572.
  • 4Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36(1):296-327.
  • 5Canepari G,Inquaqqiato P,Giqliola G,et al.Continuous renal replacement therapies (CRRT)[J].GItal Nefrol,2006,23 (36):30.
  • 6Ullrich R,Rocder G,Lorber C,et al.Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs[J].Anesthesiology,2001,95(2):428-436.

同被引文献263

引证文献33

二级引证文献226

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部